8-K
Current Report
Trevi Therapeutics, Inc. Filed Acc 0001564590-22-024091
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading trvi-8k_20220623.htm…